Do you have space in your portfolio for some new additions? If you do, then it could pay to listen to what analysts are saying about the ASX shares named below, courtesy of The Bull.
Here's what they are recommending as buys:
Image source: Getty Images
Harvey Norman Holdings Ltd (ASX: HVN)
Sanlam Private Wealth thinks that investors should be buying retail giant Harvey Norman.
It likes the company's exposure to artificial intelligence-related products and improvements in consumer sentiment at this very important time of the year. It said:
Improving consumer sentiment favours this retail giant leading into the usually strong Christmas trading period. Electronics and furniture are expected to perform well, particularly in artificial intelligence-related products amid strong interest in the latest iPhone. HVN's franchising operations are enjoying robust pre-tax margins as costs remain well contained compared to last year. Aggregate sales for Australian franchisees increased 6.5 per cent between July 1 and November 20, 2025, when compared to the prior corresponding period.
Ramsay Health Care Ltd (ASX: RHC)
Over at Family Financial Solutions, it thinks that private hospital operator Ramsay Health Care could be an ASX share to buy.
It highlights that its shares trade at a deep discount to what it believes is fair value. Its analysts said:
Ramsay is one of Australia's largest private hospital operators. Strong fundamentals and margin recovery support long term growth. In Australia, RHC reported revenue growth of 6.5 per cent in the first quarter of 2026 compared to the prior corresponding period. Earnings before interest and tax rose 5.8 per cent. RHC expects EBIT growth in full year 2026. Ramsay's shares remain undervalued relative to our fair value estimate of $54, as we expect profitability to improve through higher indexation, digital efficiencies and easing wage pressures. The shares were trading at $37.23 on December 4.
Tyro Payments Ltd (ASX: TYR)
Family Financial Solutions also thinks that payments company Tyro could be an ASX share to buy.
As with Ramsay, it feels that Tyro Payments shares are significantly undervalued at current levels. It explains:
Tyro provides electronic payment solutions and banking services to Australian businesses. The company reaffirmed fiscal 2026 guidance for normalised gross profit of between $230 million and $240 million and an EBITDA margin of between 28.5 per cent and 30 per cent. Tyro is launching a new banking platform to boost merchant adoption. Tyro's modern technology and strong performance support growth. Shares remain below our fair value estimate of $1.30, so we recommend accumulating the stock. The shares were trading at $1.037 on December 4.
